Direkt zum Inhalt
Merck
  • [Research progress on the efficacy, metabolism and bioavailability of mebendazole in hydatid disease].

[Research progress on the efficacy, metabolism and bioavailability of mebendazole in hydatid disease].

Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases (2010-03-18)
Cong-Shan Liu, Hao-Bing Zhang
ZUSAMMENFASSUNG

Mebendazole is currently used in the treatment of hydatid disease. Its poor absorption from the gastrointestinal tract and low bioavailability aroused further research on new formulations of mebendazole to increase the bioavailability and improve the therapeutic efficacy. This review summarizes the recent research progress.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

USP
Mebendazol, United States Pharmacopeia (USP) Reference Standard
Supelco
Mebendazol, analytical standard, ≥98% (HPLC)
Supelco
Mebendazol, VETRANAL®, analytical standard
Mebendazol, European Pharmacopoeia (EP) Reference Standard
Mebendazol für die Systemeignung, European Pharmacopoeia (EP) Reference Standard